Systemic lupus erythematosus is associated with increased risk of mortality and acute kidney injury in patients with COVID-19 hospitalization: Insights from a National Inpatient Sample analysis

CONCLUSION: COVID-19 patients with SLE are at an increased mortality risk, especially in the younger age group, and a higher incidence of acute kidney injury requiring dialysis. The elevated risk of adverse outcomes underscores the vulnerability of SLE patients to COVID-19. These findings emphasize the importance of special precautions and patient education for individuals with SLE to mitigate the risks associated with COVID-19.PMID:38194931 | DOI:10.1177/09612033241227027

Source: Lupus - January 9, 2024 Category: Rheumatology Authors: Anum Akhlaq Sameen Aamer Khawaja Muthammir Hasan Taimur Sohail Muzammil Amir Humza Sohail Mohammed A Quazi Muhammad Salman Khan Abu Baker Sheikh Source Type: research